Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches-Reference-Cited by-同舟云学术

Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches

Published:2021-09 Issue: Volume:337 Page:27-58
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Ghosh Saikat,Javia Ankit,Shetty Saritha,Bardoliwala Denish,Maiti Kuntal,Banerjee Shubhadeep,Khopade Ajay,Misra Ambikanandan,Sawant Krutika,Bhowmick Subhas

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference316 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Triple-negative breast cancer: treatment challenges and solutions;Collignon;Breast Cancer: Targets and Therapy.,2016

3. The rates of second lung cancers and the survival of surgically-resected second primary lung cancers in patients undergoing resection of an initial primary lung cancer;Varlotto;Lung Cancer,2020

4. A brief report of transformation from NSCLC to SCLC: molecular and therapeutic characteristics;Ferrer;J. Thorac. Oncol.,2019

5. Liposome-Based Drug Delivery for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer;Skupin-Mrugalska,2019

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

2. Construction and evaluation of liposomal drug delivery system for an ALK/HDACs dual-targeted inhibitor with sustained release and enhanced antitumor effect;Drug Delivery and Translational Research;2024-08-07

3. Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer;Acta Pharmaceutica Sinica B;2024-08

4. Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects;Frontiers in Pharmacology;2024-07-12

5. Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling;Biomolecules;2024-06-23